217 related articles for article (PubMed ID: 3546388)
1. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.
Smith ME; Holgate CS; Williamson JM; Grigor I; Quirke P; Bird CC
J Clin Pathol; 1987 Jan; 40(1):34-41. PubMed ID: 3546388
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
4. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests.
Faust A; Neppert J
J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673
[TBL] [Abstract][Full Text] [Related]
9. Gamma interferon induces detectable serological and functional expression of DR and DP but not DQ antigens on cultured amniotic fluid cells.
Maurer DH; Callaway C; Sorkin S; Pollack MS
Tissue Antigens; 1988 Apr; 31(4):174-82. PubMed ID: 3136555
[TBL] [Abstract][Full Text] [Related]
10. Oncogene-derived peptides: a new class of tumor rejection antigens?
Gedde-Dahl T; Olsen BH; Thorsby E; Gaudernack G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1385-6. PubMed ID: 8442151
[No Abstract] [Full Text] [Related]
11. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
[TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
13. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
15. The role of HLA class II antigens in the induction of cytotoxic T lymphocytes.
Demesová V; Buc M; Ferencík S; Sasazuki T; Shawkatová I; Porubská S
Eur J Immunogenet; 1995 Dec; 22(6):425-34. PubMed ID: 8597559
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut.
Oliver AM; Thomson AW; Sewell HF; Abramovich DR
Scand J Immunol; 1988 Jun; 27(6):731-7. PubMed ID: 3293192
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
18. Differential tissue distribution of HLA-DR, -DP and -DQ antigens.
Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U
Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525
[No Abstract] [Full Text] [Related]
19. Expression of class II antigens by subsets of activated T cells.
Zier KS
Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of class II MHC antigens in placentae from patients with pemphigoid gestationis: analysis of class II MHC subregion product expression.
Borthwick GM; Holmes RC; Stirrat GM
Placenta; 1988; 9(1):81-94. PubMed ID: 3283723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
